StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Cesium carbonate → 1-(6-(5-(6-isopropoxypyrazin-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine

HRID 1529261
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 1529261
C(=O)([O-])[O-].[Cs+].[Cs+].[CH:7]([O:10][C:11]1[CH:16]=[N:15][CH:14]=[C:13](B2OC(C)(C)C(C)(C)O2)[N:12]=1)([CH3:9])[CH3:8].Br[C:27]1[CH:28]=[C:29]2[C:33](=[CH:34][CH:35]=1)[N:32](C1CCCCO1)[N:31]=[C:30]2[C:42]1[N:47]=[C:46]([N:48]2[CH2:53][CH2:52][CH:51]([NH:54]C(=O)OC(C)(C)C)[CH2:50][CH2:49]2)[CH:45]=[N:44][CH:43]=1>[Cu]I.C1(P(C2C=CC=CC=2)[C-]2C=CC=C2)C=CC=CC=1.[C-]1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=C1.[Fe+2].C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[CH:7]([O:10][C:11]1[N:12]=[C:13]([C:27]2[CH:28]=[C:29]3[C:33](=[CH:34][CH:35]=2)[NH:32][N:31]=[C:30]3[C:42]2[N:47]=[C:46]([N:48]3[CH2:49][CH2:50][CH:51]([NH2:54])[CH2:52][CH2:53]3)[CH:45]=[N:44][CH:43]=2)[CH:14]=[N:15][CH:16]=1)([CH3:8])[CH3:9]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 3

HCID 10796Cesium carbonateHCID 457862332-Isopropoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazineHCID 67959723tert-butyl 1-(6-(5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-ylcarbamate2×

Produkt 1

HCID 679596291-(6-(5-(6-isopropoxypyrazin-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)Katalysator
HCID 167845palladium(II) acetateKatalysator
HCID 635956Ferrocene-1,1'-bis-(diphenylphosphine)Katalysator

Reaktionsbedingungen

Temperatur
80 °C

Versuchsvorschrift

A mixture of CuI (Aldrich, 26.6 mg, 0.27 mmol), cesium carbonate (Aldrich, 351 mg, 1.08 mmol), 1,1′-bis(diphenylphosphino)ferrocene (14.9 mg, 0.03 mmol), palladium(II) acetate (Strem Chemicals, 3.0 mg, 0.01 mmol), 2-isopropoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine (Combi-Phos, 142 mg, 0.54 mmol), and tert-butyl 1-(6-(5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-ylcarbamate (compound 1e, 150 mg, 0.27 mmol) in a 5 mL conical microwave vial was sealed, evacuated and back-filled with N2 3×. DMF (2.7 mL) was added, and the reaction mixture was stirred at 80° C. for 16 h. The resulting reaction mixture was cooled to RT, filtered, and concentrated to dryness. The crude product was purified by HPLC (5 to 80% 0.1% TFA:Water:0.1% TFA:ACN over 25 min). The fractions were combined, washed with sat. aq. NaHCO3 and extracted with 20% IPA in chloroform. The combined organics were dried over Na2SO4, filtered, and concentrated under reduced pressure to a tan oil. The oil was dissolved in MeOH/DCM before adding 6 N HCl in IPA and stirring at 80° C. for 2 h. The reaction mixture was concentrated under reduced pressure before resolubilizing with MeOH and passing through a MeOH washed plug of Si-propylsulfonic acid. The compound was released with 2M NH3 in MeOH (30 mL) to afford 1-(6-(5-(6-isopropoxypyrazin-2-yl)-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine as a dark tan solid. MS (ESI, pos. ion) m/z: 431 (M+1).

Aufarbeitung

  1. customwas sealed
  2. customevacuated
  3. additionback-filled with N2 3×
  4. additionDMF (2.7 mL) was added
  5. customThe resulting reaction mixture
  6. temperaturewas cooled to RT
  7. filtrationfiltered
  8. concentrationconcentrated to dryness
  9. customThe crude product was purified by HPLC (5 to 80% 0.1% TFA:Water:0.1% TFA:ACN over 25 min)
  10. washwashed with sat. aq. NaHCO3
  11. extractionextracted with 20% IPA in chloroform
  12. dry with materialThe combined organics were dried over Na2SO4
  13. filtrationfiltered
  14. concentrationconcentrated under reduced pressure to a tan oil
  15. dissolutionThe oil was dissolved in MeOH/DCM
  16. additionbefore adding 6 N HCl in IPA
  17. stirringstirring at 80° C. for 2 h
  18. concentrationThe reaction mixture was concentrated under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-0fdcc7d2316d4df6be21c40b0766f6d7
Quelldatensatz
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US09090593B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion